Thomas Albon is a Research Technologist in the Research and Development Department at STEMCELL Technologies Ltd., Cambridge, UK. He currently works in the team led by Senior Scientist Dr. Salvatore Simmini, developing innovative products for differentiating and culturing specialized cell types derived from both pluripotent stem cells (PSCs) and primary tissues. Thomas received his BSC in biological sciences from the University of Reading. During that time he performed his research under the supervision of Dr. Chris Jones using convolution neural networks to investigate platelet function during thrombosis. Thomas’ industry experience includes time as a research assistant at a CRO performing GLP studies within the Genetic toxicology department, testing prospective pharmaceuticals and agricultural compounds.
STEMCELL Technologies Inc. is a privately-owned biotechnology company based in Vancouver that helps power leading-edge life science research around the world. Scientists performing stem cell, immunology, cancer, regenerative medicine and cellular therapy research are among those who rely on our cell culture media, cell separation products, instruments, ancillary reagents and contract assay services. We create novel, useful, standardized products of unfailing quality and deliver them to more than 70 countries via our many regional offices plus distribution centres in Vancouver, Seattle, Grenoble and Singapore. Driven by our love of science and our passion for quality, we see ourselves simply as “Scientists Helping Scientists” – standing by our customers to provide outstanding products, technical support and training. We have over 1000 science-oriented employees globally, including 250 PhDs/MScs, with most others holding a BSc or engineering degree. STEMCELL is proud to be the largest Biotechnology employer in Canada.
STEMCELL is continuing to expand its European operations, particularly in the areas of R&D personnel and facilities, manufacturing, quality control, quality assurance and regulatory activities that will meet the highest levels of European research and regular standards. STEMCELL UK Ltd. (STUK) was established in July 2014. In 2016 STUK expanded its capabilities to include research and development (R&D) with staff located in laboratory space in Cambridge, UK, including fully functional laboratory space containing state of the art cell culture and analytical chemistry equipment as well as an ISO 13485-certified manufacturing clean room that is adopting single use technology and closed systems for manufacturing higher compliance media and culture reagents.